Narendra D. Lalwani Ph.D., FAHA, DABT, MBA — Chief Operating Officer and Executive Vice President of Research & Development at Esperion Therapeutics | Comparably
Esperion Therapeutics Claimed Company
Esperion is a pharmaceutical company that specializes in developing and commercializing oral therapies for the treatment of patients with elevated LDL-C. read more
EMPLOYEE
PARTICIPANTS
19
TOTAL
RATINGS
316
HR or Marketing? Claim Your Free Employer Account
Narendra D. Lalwani Ph.D., FAHA, DABT, MBA — Chief Operating Officer and Executive Vice President of Research & Development at Esperion Therapeutics

Narendra D. Lalwani Ph.D., FAHA, DABT, MBA — Chief Operating Officer and Executive Vice President of Research & Development at Esperion Therapeutics

Executive Bio

Dr. Naredra D. Lalwani, Ph.D., FAHA, DABT, MBA has been the Chief Operating Officer and Executive Vice President of Research & Development at Esperion Therapeutics, Inc. since August 1, 2014. Dr. Lalwani has over 20 years of experience in the research and development of product candidates in the life science industry. Dr. Lalwani served as the Chief Scientific Officer at Cerenis Therapeutics from June 2007 to January 2014, where he led R&D activities for it. He served as Senior Director of Drug Safety Research and Development at Pfizer, Inc., from February 2004 to June 2007. Previously, he served as Vice President of Drug Safety Evaluation and a Member of the Executive Leadership team in the prior Esperion Therapeutics, Inc., since its inception in 1998 until its acquisition by Pfizer in 2004 and worked in the Department of Pathology and Experimental Toxicology at Parke-Davis Pharmaceutical Research, Warner-Lambert from 1990 to 1997. He is a Diplomate of the American Board of Toxicology and also a Fellow of the American Heart Association. Dr. Lalwani holds a MS and a Ph.D. in Biophysics from the University of Bombay, a BS in Microbiology and Chemistry from Gujarat University and an MBA from the Ross School of Business, University of Michigan.

Chief Operating Officer and Executive Vice President of Research & Development Impact on Operations Department's Culture

Narendra D. Lalwani Ph.D., FAHA, DABT, MBA holds the highest position within the Operations department at Esperion Therapeutics — Chief Operating Officer and Executive Vice President of Research & Development, and therefore has influence on the culture of the Operations department.

AnswerPercent
YesNaN%
NoNaN%
Are you challenged at work?
AnswerPercent
YesNaN%
NoNaN%
Are your company's goals clear, and are you invested in them?
AnswerPercent
YesNaN%
NoNaN%
Are you satisfied with your work/life balance?
AnswerPercent
Positive0%
Negative0%
Is your work environment positive or negative?
AnswerPercent
Great0%
Good0%
Average0%
Poor0%
Horrible0%
How would you rate the value & quality of meetings at your company?
AnswerPercent
YesNaN%
NoNaN%
Does your current company provide you meaningful opportunities for career advancement?

Executive Team Culture Ratings from Esperion Therapeutics Employees

BOTTOM
5%
Esperion Therapeutics' Executive Team scores in the Bottom 5%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Gender - Female 14/100
Ethnicity - Caucasian 14/100
Experience - Over 10 Years 14/100
Who ranks the Executive Team the lowest?
Not Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Esperion Therapeutics

Esperion Therapeutics' Executive Team at a Glance

Based on 17 ratings, Esperion Therapeutics' employees are less satisfied with their Executive Team and give them a ā€œFā€ or 21/100.

Esperion Therapeutics' Executive Team ranks in the Bottom 5% of other companies in Flint, MI and Bottom 5% of other companies on Comparably that also have 51-200 Employees.

×
Rate your company